These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 22006503)

  • 21. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none?
    Khalili K; Kim TK; Jang HJ; Yazdi LK; Guindi M; Sherman M
    Hepatology; 2011 Dec; 54(6):2048-54. PubMed ID: 22057624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance and early diagnosis of hepatocellular carcinoma.
    Lencioni R
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S223-7. PubMed ID: 20547307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
    Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
    Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report.
    Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC
    Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EUS for detection of the hepatocellular carcinoma: results of a prospective study.
    Singh P; Erickson RA; Mukhopadhyay P; Gopal S; Kiss A; Khan A; Ulf Westblom T
    Gastrointest Endosc; 2007 Aug; 66(2):265-73. PubMed ID: 17543307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
    Bolondi L; Gaiani S; Celli N; Golfieri R; Grigioni WF; Leoni S; Venturi AM; Piscaglia F
    Hepatology; 2005 Jul; 42(1):27-34. PubMed ID: 15954118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
    Park VY; Choi JY; Chung YE; Kim H; Park MS; Lim JS; Kim KW; Kim MJ
    Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
    Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
    Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
    Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
    Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.
    Rimola J; Forner A; Tremosini S; Reig M; Vilana R; Bianchi L; Rodríguez-Lope C; Solé M; Ayuso C; Bruix J
    J Hepatol; 2012 Jun; 56(6):1317-23. PubMed ID: 22314420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
    Fowler KJ; Sheybani A; Parker RA; Doherty S; M Brunt E; Chapman WC; Menias CO
    AJR Am J Roentgenol; 2013 Aug; 201(2):332-9. PubMed ID: 23883213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.